Published in Ther Drug Monit on January 01, 1988
HPLC estimation of iothalamate to measure glomerular filtration rate in humans. Chem Cent J (2016) 0.75
Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial. Lancet (2001) 3.01
Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation. Int J Clin Pract (2011) 2.25
AmBisome (liposomal amphotericin B): a comparative review. J Clin Pharmacol (1998) 2.08
Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemother (2001) 2.03
Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. Clin Pharmacol Ther (1997) 1.55
Clinical consequences of polymorphic acetylation of basic drugs. Clin Pharmacol Ther (1977) 1.50
Are the risk factors listed in warfarin prescribing information associated with anticoagulation-related bleeding? A systematic literature review. Int J Clin Pract (2011) 1.41
Biochemical site of regulation of bile acid biosynthesis in the rat. J Lipid Res (1970) 1.40
Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med (1978) 1.37
Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients. Antimicrob Agents Chemother (1998) 1.37
Understanding heterogeneity in meta-analysis: the role of meta-regression. Int J Clin Pract (2009) 1.34
Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits. Antimicrob Agents Chemother (2001) 1.34
Polymorphic acetylation procainamide in man. Clin Pharmacol Ther (1975) 1.32
Optimizing metoclopramide control of cisplatin-induced emesis. Ann Intern Med (1984) 1.30
Anterior S-T segment depression in acute inferior myocardial infarction: indicator of posterolateral infarction. Am J Cardiol (1981) 1.26
Plasma protein binding of ceftriaxone. Xenobiotica (1987) 1.24
Feedback regulation of bile acid biosynthesis in the rat. J Lipid Res (1969) 1.22
Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: an overview. Clin Pharmacol Ther (1986) 1.21
Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography. J Lab Clin Med (1977) 1.13
Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function. Clin Pharmacol Ther (1978) 1.13
A high-performance liquid chromatographic assay for the determination of amphotericin B serum concentrations after the administration of AmBisome, a liposomal amphotericin B formulation. Ther Drug Monit (1996) 1.12
Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals. Am J Med (1984) 1.12
Determination of 1,4-benzodiazepines and -diazepin-2-ones in blood by electron-capture gas-liquid chromatography. Anal Chem (1976) 1.12
Toxicological profile and pharmacokinetics of a unilamellar liposomal vesicle formulation of amphotericin B in rats. Antimicrob Agents Chemother (1998) 1.09
The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups. Clin Pharmacol Ther (2001) 1.09
Mechanisms governing the postural response and baroreceptor abnormalities in chronic congestive heart failure: effects of acute and long-term converting-enzyme inhibition. Circulation (1982) 1.08
The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril). Am J Cardiol (1982) 1.02
Improved synthesis of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA). J Lipid Res (1969) 1.01
Aging and renal clearance of procainamide and acetylprocainamide. Clin Pharmacol Ther (1980) 1.01
Evaluation of electrocardiographic and hemodynamic effects of caffeine with acute dosing in healthy volunteers. Pharmacotherapy (2001) 1.00
An evaluation of the impact of gender and age on QT dispersion in healthy subjects. Ann Noninvasive Electrocardiol (2001) 1.00
Alteration of drug-protein binding in renal disease. Clin Pharmacokinet (1984) 0.99
Changes in P-wave dispersion and P-wave duration after open heart surgery are associated with the peak incidence of atrial fibrillation. Heart Lung (2001) 0.97
Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers. J Clin Pharmacol (1999) 0.96
In vitro acetylation of drugs by human blood cells. Drug Metab Dispos (1975) 0.95
Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide. N Engl J Med (1979) 0.94
Stereoselective renal tubular secretion of quinidine and quinine. Clin Pharmacol Ther (1986) 0.94
Sympathetic responsiveness and plasma norepinephrine during therapy of chronic congestive heart failure with captopril. Am J Med (1982) 0.94
Determination of clonazepam and flunitrazepam in blood by electron-capture gas-liquid chromatography. J Chromatogr (1974) 0.94
Lipophilic beta-blockers inhibit rat skeletal muscle mitochondrial respiration. Pharmacology (1993) 0.94
Effect of chronic oral moricizine and intravenous epinephrine on ventricular fibrillation and defibrillation thresholds. Pacing Clin Electrophysiol (1996) 0.92
Increased excretion of urinary N-acetyl-beta-glucosaminidase in essential hypertension and its decline with antihypertensive therapy. N Engl J Med (1983) 0.92
Renal clearance of carprofen in the isolated perfused rat kidney. Drug Metab Dispos (1981) 0.91
The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death. J Intern Med (2006) 0.90
N-acetyl-beta-glucosaminidase and beta 2-microglobulin. Their urinary excretion in patients with renal parenchymal disease. Arch Intern Med (1983) 0.90
Quantitation of free and total amphotericin B in human biologic matrices by a liquid chromatography tandem mass spectrometric method. Ther Drug Monit (2001) 0.89
Use of the isolated perfused kidney as a tool in drug disposition studies. Drug Metab Rev (1983) 0.88
Development of antinuclear antibody in patients treated with high doses of captopril. Arthritis Rheum (1984) 0.88
Demographic considerations in tacrolimus pharmacokinetics. Transplant Proc (1998) 0.87
Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure. Clin Pharmacokinet (1977) 0.87
Aromatic amines and hydrazines drug acetylation, and lupus erythematodes. Hum Genet Suppl (1978) 0.86
Relative and absolute bioavailability of prednisone and prednisolone after separate oral and intravenous doses. J Clin Pharmacol (1988) 0.86
Pubertal changes in net renal tubular secretion of digoxin. Clin Pharmacol Ther (1984) 0.86
Tacrolimus pharmacokinetics in BMT patients. Bone Marrow Transplant (1998) 0.86
Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus. Arthritis Rheum (1993) 0.86
N-acetylprocainamide: an active metabolite of procainamide. Proc Soc Exp Biol Med (1974) 0.86
Effects of renal disease upon drug disposition. Drug Metab Rev (1978) 0.86
Possible recurrence of amiodarone pulmonary toxicity following corticosteroid therapy. Chest (1984) 0.86
The determination of 7-chloro-1,3-dihydro-5-(2',chlorophenyl)-2H-1,4-benzodiazepin-2-one (Ro 5-3027) and its metabolite (lorazepam) in blood and urine by electron-capture gas liquid chromatography. J Chromatogr Sci (1973) 0.85
Efficacy of intravenous granisetron in suppressing the bradycardia and hypotension associated with a rabbit model of the Bezold-Jarisch reflex. J Clin Pharmacol (1998) 0.85
Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerations. Drugs (1982) 0.85
Acetylator phenotype in idiopathic systemic lupus erythematosus. Arthritis Rheum (1980) 0.84
Amiodarone in the new AHA guidelines for ventricular tachyarrhythmias. Ann Pharmacother (2001) 0.84
Biodistribution of 4-[(14)C]cholesterol-AmBisome following a single intravenous administration to rats. Drug Metab Dispos (2001) 0.84
Factors associated with 'caregiver burden' for atrial fibrillation patients. Int J Clin Pract (2012) 0.83
Epoprostenol sodium (prostacyclin) infusion in acute myocardial infarction. Br Heart J (1986) 0.83
Effects of amiodarone and its active metabolite desethylamiodarone on the ventricular defibrillation threshold. J Am Coll Cardiol (1998) 0.83
Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group. Am J Cardiol (1991) 0.83
Recipient preconditioning and donor-specific bone marrow infusion in a pig model of total bowel transplantation. Transplantation (1997) 0.83
Variant late-infantile neuronal ceroid lipofuscinosis due to a novel heterozygous CLN8 mutation and de novo 8p23.3 deletion. Clin Genet (2011) 0.82
Hematologic and chemical changes observed during and after cardiac arrest in a canine model--a pilot study. Pharmacotherapy (2001) 0.82
Improved method for the measurement of cimetidine in human serum by reverse-phase high-pressure liquid chromatography. J Lab Clin Med (1981) 0.82
Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey. Transplantation (2000) 0.82
A comparison of the antifibrillatory effects of desethylamiodarone to amiodarone in a swine model. J Cardiovasc Pharmacol (1999) 0.82
Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages. Clin Pharmacol Ther (1983) 0.82
Drug therapy in renal failure. Annu Rev Pharmacol Toxicol (1980) 0.82
Prophylactic magnesium to decrease the arrhythmogenic potential of class III antiarrhythmic agents in a rabbit model. Pharmacotherapy (1999) 0.82
A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation. Transplantation (1995) 0.82
Age and renal clearance of cimetidine. Clin Pharmacol Ther (1982) 0.82
Quantitation of myocardial dysfunction in ischemic heart disease by echocardiographic endocardial surface mapping: correlation with hemodynamic status. Am Heart J (1995) 0.82
Grapefruit juice and its flavonoids inhibit 11 beta-hydroxysteroid dehydrogenase. Clin Pharmacol Ther (1996) 0.81
Usefulness of intravenous granisetron for prevention of neurally mediated hypotension upon head upright tilt testing. Am J Cardiol (2000) 0.81
An evaluation of the change in electrocardiographic P-wave variables after acute caffeine ingestion in normal volunteers. J Clin Pharm Ther (2001) 0.81
Lidocaine prophylaxis for fatal ventricular arrhythmias after acute myocardial infarction. Clin Pharmacol Ther (1995) 0.81
Tacrolimus (FK506) ointment for atopic dermatitis: a phase I study in adults and children. J Am Acad Dermatol (1998) 0.81
Metabolism of salicylic acid in the isolated perfused rat kidney. Interconversion of salicyluric and salicyclic acids. Drug Metab Dispos (1981) 0.80
Compromised kidney graft rejection response in Vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus. Transplantation (2000) 0.80
In utero-exposure to saccharin: a threat? Cancer Lett (1986) 0.80
What mother nature teaches us about motherhood. Time (2000) 0.80
Cumulation of N-acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function. Clin Pharmacol Ther (1977) 0.80
Acetylation of sulfisoxazole by isolated perfused rat kidney. J Pharm Sci (1980) 0.80
The effect of lidocaine and bretylium on the defibrillation threshold during cardiac arrest and cardiopulmonary resuscitation. Proc Soc Exp Biol Med (1986) 0.80
Correlation of the electrophysiological and antiarrhythmic properties of the N-acetyl metabolite of procainamide with plasma and tissue drug concentrations in the dog. J Pharmacol Exp Ther (1976) 0.79
Acetylprocainamide therapy in patients with previous procainamide-induced lupus syndrome. Ann Intern Med (1981) 0.79
Hydromorphone levels and pain control in patients with severe chronic pain. Clin Pharmacol Ther (1988) 0.79
Differences in systemic and myocardial blood acid-base status during cardiopulmonary resuscitation. Crit Care Med (1989) 0.79